重编程和多系转基因差异化减弱了结直肠癌细胞的瘤性
Tongtong Guo1, Juan Wang1, Maogui Pang2
1State Key Laboratory of Cancer Biology and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, Shaanxi, China.
The Journal of biological chemistry
|December 10, 2023
概括
结肠直肠癌细胞被重新编程成诱导多能干细胞 (iPSC),显示出恶性病变减少. 这些细胞进一步分化为各种细胞类型,显示出更低的瘤发生,这表明一种新的癌症治疗方法.
科学领域:
- 干细胞生物学 干细胞生物学
- 癌症研究 癌症研究
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 将体细胞重新编程成诱导多能干细胞 (iPSC) 和转分化是先进的技术.
- 这些方法有可能通过将恶性表型转换为良性表型来治疗癌症.
- 关于重编程癌细胞以减少恶性瘤的研究有限.
研究的目的:
- 为了研究大肠直肠癌 (CRC) 细胞重新编程成iPSCs.
- 评估重编程的CRC细胞及其分化后代的瘤发生.
- 探索多谱系分化作为CRC治疗策略的潜力.
主要方法:
- 将两个CRC细胞系 (DLD1,HT29) 重编程为iPSC (D-iPSC,H-iPSC).
- 诱导D-和H-iPSCs分化为心肌细胞,神经元和脂肪细胞类细胞.
- 在体外和体内评估重新编程和分化细胞中的瘤发生.
- RNA测序 (RNA-Seq) 分析以确定表观遗传变化.
主要成果:
- CRC细胞系成功地被重新编程成具有减少瘤发生率的iPSC.
- 从这些iPSC中分化的细胞在体外和体内表现出进一步减弱的恶性瘤.
- RNA-Seq揭示了表观遗传修饰,与重编程和分化后减少瘤性相关.
结论:
- 结肠直肠癌细胞可以被重新编程成iPSC,然后分化成各种细胞类型.
- 这一过程在体外和体内都显著减轻了癌细胞恶性病变.
- 重编程的CRC细胞的多谱系分化为结直肠癌提供了一个有前途的治疗策略.
相关概念视频
Forced Transdifferentiation
1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.9K
Introduction to Nuclear Reprogramming
1.9K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.9K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


